ID3 and metastatic neoplasm: Conversely, as predicted from the genetic analyses47, Vimentin staining of small metastatic tumors in the AGX51 group was significantly higher than that in the DMSO group (Fig. 5d), consistent with a reduction in Id1/Id3 levels blocking the mesenchymal-to-epithelial transition during metastatic progression.